This story was originally published on Retail Dive. To receive daily news and insights, subscribe to our free daily Retail Dive newsletter. Dive Brief: Family Dollar plans to pilot a new extra small box store format intended for dense urban areas in 2026, the company said in a Tuesday press release. The discount retailer generated about $13 billion in revenue and comparable sales growth of 2.5% in fiscal year 2025, per the release. In 2026, Family Dollar expects positive comparable store sales growth. ...

RT Nic Cruz Patane (@niccruzpatane)PBD Podcast on Elon Musk:“Whoever creates the most value for everybody else should end up with the most resources. Name somebody who’s done it better than him.Elon Musk for 30 years has averaged the creation of a multi-billion dollar company every 5 years. There’s nobody in the world who’s ever done that before. It is incredible, and it’s not like, ‘Oh, let me go do a roll-up of everybody else’s businesses’—it’s not financial engineering, it is from scratch: ‘we’re going t ...

Focused. Disciplined. Experienced. Corporate Presentation March 2026 1 TSX | KEL Why Invest in Kelt ? Value Creation Kelt focuses on value creation for shareholders over the long-term. We emphasize low-cost land accumulation in resource-style plays with the potential for high rates of return on capital invested and rapid growth of its drilling inventory portfolio. Management and the Board are aligned with all Kelt shareholders through their significant equity ownership in the Company. The Kelt management te ...

Summary of Huntington Bancshares Conference Call Company Overview - **Company**: Huntington Bancshares (NasdaqGS: HBAN) - **Date**: March 11, 2026 - **Key Speakers**: Brant Standridge (President of Consumer and Regional Banking), Zach Wasserman (CFO) Core Industry Insights - Huntington operates as a **super regional bank** with a focus on differentiated banking services across various customer segments, including consumer, small business, and middle-market clients [5][6] - The bank has successfully integrated partnerships with **Veritex** and **Cadence**, enhancing its growth capacity and market reach [5][12] Key Financial Metrics - As of year-end, Huntington reported approximately **$70 billion in loans** and **$51 billion in deposits** [6] - The bank is targeting **11%-12% loan growth** and **8%-9% deposit growth** for 2026 [10] - Core business performance showed **$1.2 billion in loan growth** and **$1.3 billion in deposit growth** in the first quarter, excluding Cadence [9] Strategic Initiatives - Huntington's model emphasizes **organic growth** through customer acquisition and deeper relationships, supported by a disciplined integration approach for new partnerships [5][10] - The bank has a **21 regional presidents** structure, allowing local decision-making and accountability [8] - The integration of Veritex was completed in **187 days**, with expected cost synergies of **$435 million** at full run rate [11][12] Revenue and Cost Synergies - Expected cost synergies from the partnerships are projected to reduce 2026 operating expenses by approximately **$340 million**, with an additional **$100 million** benefit in 2027 [12] - Revenue synergies are anticipated to exceed **$500 million** over the next three years, with **$150 million** expected in 2027 [17][48] Shareholder Value Creation - Huntington plans to return approximately **$550 million** through share repurchases in 2026, significantly higher than the initial expectation of **$200 million** [22][23] - The bank aims for a **30% growth in earnings per share** by 2027, targeting **$1.90-$1.93** per share [20][21] Market Position and Competition - The bank acknowledges competitive pressures in the Texas and Southeastern markets but remains confident in its growth trajectory [36] - A focus on building primary bank relationships has been key to strong deposit growth [38] Risk Management and Outlook - The bank maintains a moderate to low risk appetite, with a clear line of sight to sustained growth and expanding earnings power [20] - Current market conditions are being monitored closely, but no significant adverse impacts have been observed on business performance [52][53] Conclusion - Huntington Bancshares is positioned for robust growth through strategic partnerships, disciplined execution, and a focus on shareholder value, with a strong outlook for 2026 and beyond [25][56]

Money is Just a Tool: We Create the Real Value! Ever thought about what really drives value? It’s not just cash—it’s the creativity, hard work, and passion of people like you! #shorts #money #bitcoin #crypto #finance #investing #wealth ...

Financial Data and Key Metrics Changes - In Q4 2025, net product revenues were $22.3 million, up from $16.4 million in Q4 2024, indicating a strong performance [21] - For the full year 2025, net product revenues reached $73.6 million, compared to $69.3 million in 2024, showing stability in revenue generation [21] - Total operating expenses for Q4 2025 were $41 million, while for the full year, they were $202.9 million, reflecting a disciplined approach to cost management [21][22] - The net loss for Q4 2025 was $6.4 million, significantly reduced from a loss of $30.7 million in Q4 2024 [22][23] Business Line Data and Key Metrics Changes - The focus on ZYNLONTA has led to a refined go-to-market model, maintaining its position in the third-line plus DLBCL setting despite increased competition from bispecific therapies [5][6] - The company anticipates significant growth opportunities in the second-line plus DLBCL setting with LOTIS-5, expecting to share top-line data in Q2 2026 [8][10] Market Data and Key Metrics Changes - The treatment landscape for DLBCL is evolving, with a current 60/40 split between complex therapies and broadly accessible therapies, impacting market dynamics [15] - The company estimates that achieving a 10% market share in the second-line setting could translate to an additional $200 million to $300 million in revenue [20] Company Strategy and Development Direction - The strategic plan focuses on optimizing lifecycle management for ZYNLONTA, including advancing LOTIS-5 and initiating LOTIS-7 [5][6] - The company aims to establish ZYNLONTA as a backbone therapy in DLBCL, targeting peak annual revenues of $600 million to $1 billion with regulatory approvals and compendia listings [7][11] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's path forward, highlighting a strengthened balance sheet and a cash runway expected to last into 2028 [10][24] - The anticipated data catalysts in 2026 are expected to drive significant long-term growth, particularly with the LOTIS-5 and LOTIS-7 trials [25][26] Other Important Information - The company has successfully reduced its operating cost structure by approximately 50%, enhancing its strategic flexibility [5][6] - The amendment to the royalty purchase agreement with HealthCare Royalty reflects the company's confidence in ZYNLONTA's long-term value [9][10] Q&A Session Summary Question: How are PFS events tracking for LOTIS-5? - Management is confident in the Q2 timing for the top-line readout and will share primary and secondary endpoints at that time [29][30] Question: Is the $200-$300 million opportunity for LOTIS-5 conservative? - Management believes the profile seen in the safety run-in supports a meaningful role in the second-line plus DLBCL market, with potential for higher peak sales depending on clinical outcomes [34][35] Question: What is the expected R&D spend moving forward? - R&D expenses are expected to decrease in 2026 and 2027, assuming the current number of trials remains stable [42][44] Question: How will capital allocation priorities be managed? - The company is focused on driving ZYNLONTA growth and has allocated capital for ongoing trials and pre-launch activities [48][50] Question: What is the current commercial run rate for ZYNLONTA? - The company has maintained its market share despite increased competition, with expectations for significant sales growth following LOTIS-5 approval [58][59]

Core Insights - The article discusses potential investment opportunities in PAYC and PAYX, indicating a possible initiation of a long position in these stocks within the next 72 hours [1]. Group 1 - The analyst has no current stock or derivative positions in the mentioned companies but may consider purchasing stocks or options soon [1]. - The article expresses the author's personal opinions and is not influenced by any compensation from the companies mentioned [1]. Group 2 - The content is intended for informational purposes and does not constitute a solicitation or recommendation for any investment actions [2]. - The information provided is without warranty and should be used at the reader's own risk, emphasizing the importance of evaluating investments based on individual circumstances [2].

Core Insights - The session features UDR's CEO, Tom Toomey, discussing the company's value creation mechanisms through operations, innovation, and capital allocation [2]. Company Overview - UDR is represented by a leadership team including CFO Dave Bragg, COO Mike Lacy, and Chris Van Ens, who plays various roles within the company [2]. - The company emphasizes the importance of understanding its position in the current market cycle and how it plans to evolve its business strategies [2].

Core Viewpoint - The company is positioned for continued earnings growth and value creation, supported by strong tenant demand and effective capital allocation [2]. Group 1: Financial Performance - The company reported solid Net Operating Income (NOI) earnings and dividend growth, driven by healthy tenant demand and increased foot traffic [2]. - The company is coming off an outstanding year, indicating a positive trend in financial performance [2]. Group 2: Leasing and Demand - Leasing remains a highlight, with strong demand across both anchor tenants and shops, contributing to rent growth [3]. - Limited new retail supply is supporting the growth in rents, allowing the company to enhance occupancy rates [3]. Group 3: Development and Growth Strategy - Development is identified as a key differentiator and the primary external growth engine for the company [3]. - The company advanced its development pipeline through both starts and completions, positioning itself for meaningful NOI contributions in 2026 and beyond [3].

Core Insights - The survey conducted by Bain & Company and StepStone Group reveals that value creation is a critical driver of success for buyout general partners (GPs) as they navigate the evolving investment landscape in 2026 [1][3][5] - There is a sustained demand for co-investments and continued growth of secondary markets as essential portfolio management tools for GPs and limited partners (LPs) [1][3] Survey Overview - The survey was conducted between December 2025 and January 2026, gathering insights from over 100 investment and investor relations professionals primarily in North America and Europe [2] - The aim was to provide a forward-looking perspective on GPs' strategies and expectations for the upcoming year, complementing historical performance data [2] Key Findings - GPs are adapting to a challenging investment environment where traditional methods of value creation, such as multiple expansion, are no longer sufficient [5] - The most significant obstacle in deal-making is valuation disagreements, which hindered many deals from closing in 2025 [8] - Approximately 25% of GPs have launched or completed a continuation vehicle recently, with around 40% planning to explore this option in the next couple of years to return capital to investors [8] - Fee pressures are reshaping fund economics, with about one-third of GPs offering scale or early-bird discounts to investors during their last fundraising [8] - The impact of AI is most pronounced in deal sourcing and due diligence, with GPs reporting the highest returns from generative AI in these areas [8]